カテゴリー： GlobalInfoResearch, 世界, 医療/バイオ

世界のフェロジピン徐放性錠剤市場2022年：1錠あたり2.5mg、1錠あたり5mg、その他

◆英語タイトル：Global Felodipine Sustained-Release Tablet Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028
	◆商品コード：GIR22MY8818 ◆発行会社（リサーチ会社）：GlobalInfoResearch ◆発行日：2022年5月（※2025年版があります。お問い合わせください。） ◆ページ数：92 ◆レポート形式：英語 / PDF ◆納品方法：Eメール（注文後2-3日） ◆調査対象地域：グローバル ◆産業分野：医薬品

◆販売価格オプション（消費税別）

Single User（1名様閲覧用）	USD3,480 ⇒換算￥528,960	見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）	USD5,220 ⇒換算￥793,440	見積依頼/購入/質問フォーム
Corporate User（同一法人内共有可）	USD6,960 ⇒換算￥1,057,920	見積依頼/購入/質問フォーム

★GlobalInfoResearchに受託調査の見積を依頼する

※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

フェロジピン徐放性錠剤市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。
GlobalInfoResearchの最新の調査によると、世界のフェロジピン徐放性錠剤の市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。

フェロジピン徐放性錠剤市場は種類と用途によって区分されます。2017年～2028年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。

種類別セグメントは次をカバーします。
・1錠あたり2.5mg、1錠あたり5mg、その他

用途別セグメントは次のように区分されます。
・高血圧治療、狭心症緩和、その他

世界のフェロジピン徐放性錠剤市場の主要な市場プレーヤーは以下のとおりです。
・Astrazeneca、NanJing Easeheal Phaemaecutical、SHANXI KANGBO BIOLOGICAL PRODUCT、Lifeon、Changzhou Siyao Pharmaceutical、Mylan、Sandoz

地域別セグメントは次の地域・国をカバーします。
・北米（米国、カナダ、メキシコ）
・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア）
・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア）
・南アメリカ（ブラジル、アルゼンチン、コロンビア）
・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ）

本調査レポートの内容は計15章あります。
・第1章では、フェロジピン徐放性錠剤製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要なフェロジピン徐放性錠剤メーカーの企業概要、2019年～2022年までのフェロジピン徐放性錠剤の価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要なフェロジピン徐放性錠剤メーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2017年～2028年までの地域別フェロジピン徐放性錠剤の販売量、売上、成長性を示しています。
・第5、6章では、2017年～2028年までのフェロジピン徐放性錠剤の種類別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2017年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2028年までの主要地域でのフェロジピン徐放性錠剤市場予測を収録しています。
・第12章では、主要な原材料、主要なサプライヤー、およびフェロジピン徐放性錠剤の産業チェーンを掲載しています。
・第13、14、15章では、フェロジピン徐放性錠剤の販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。

***** 目次(一部) *****

・市場概要
・メーカー情報（企業概要、製品概要、販売量、価格、売上）：Astrazeneca、NanJing Easeheal Phaemaecutical、SHANXI KANGBO BIOLOGICAL PRODUCT、Lifeon、Changzhou Siyao Pharmaceutical、Mylan、Sandoz
・メーカー別市場シェア
・地域別市場分析2017年-2028年
・種類別分析2017年-2028年：1錠あたり2.5mg、1錠あたり5mg、その他
・用途別分析2017年-2028年：高血圧治療、狭心症緩和、その他
・フェロジピン徐放性錠剤の北米市場規模2017年-2028年：アメリカ、カナダ、メキシコ
・フェロジピン徐放性錠剤のヨーロッパ市場規模2017年-2028年：ドイツ、イギリス、フランス、ロシア、イタリア
・フェロジピン徐放性錠剤のアジア市場規模2017年-2028年：中国、日本、韓国、インド、東南アジア、オーストラリア
・フェロジピン徐放性錠剤の南米市場規模2017年-2028年：ブラジル、アルゼンチン
・フェロジピン徐放性錠剤の中東・アフリカ市場規模2017年-2028年：サウジアラビア、トルコ、エジプト、南アフリカ
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

The Felodipine Sustained-Release Tablet market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Felodipine Sustained-Release Tablet market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Treat High Blood Pressure accounting for % of the Felodipine Sustained-Release Tablet global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While 2.5mg Per Tablet segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Felodipine Sustained-Release Tablet include Astrazeneca, NanJing Easeheal Phaemaecutical, SHANXI KANGBO BIOLOGICAL PRODUCT, Lifeon, and Changzhou Siyao Pharmaceutical, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Felodipine Sustained-Release Tablet market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
2.5mg Per Tablet
5mg Per Tablet
Others
Market segment by Application can be divided into
Treat High Blood Pressure
Relieve Angina
Others
The key market players for global Felodipine Sustained-Release Tablet market are listed below:
Astrazeneca
NanJing Easeheal Phaemaecutical
SHANXI KANGBO BIOLOGICAL PRODUCT
Lifeon
Changzhou Siyao Pharmaceutical
Mylan
Sandoz
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Felodipine Sustained-Release Tablet product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Felodipine Sustained-Release Tablet, with price, sales, revenue and global market share of Felodipine Sustained-Release Tablet from 2019 to 2022.
Chapter 3, the Felodipine Sustained-Release Tablet competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Felodipine Sustained-Release Tablet breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Felodipine Sustained-Release Tablet market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Felodipine Sustained-Release Tablet.
Chapter 13, 14, and 15, to describe Felodipine Sustained-Release Tablet sales channel, distributors, customers, research findings and conclusion, appendix and data source.

❖ レポートの目次 ❖

1 Market Overview
1.1 Felodipine Sustained-Release Tablet Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Felodipine Sustained-Release Tablet Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 2.5mg Per Tablet
1.2.3 5mg Per Tablet
1.2.4 Others
1.3 Market Analysis by Application
1.3.1 Overview: Global Felodipine Sustained-Release Tablet Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Treat High Blood Pressure
1.3.3 Relieve Angina
1.3.4 Others
1.4 Global Felodipine Sustained-Release Tablet Market Size & Forecast
1.4.1 Global Felodipine Sustained-Release Tablet Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Felodipine Sustained-Release Tablet Sales in Volume (2017-2028)
1.4.3 Global Felodipine Sustained-Release Tablet Price (2017-2028)
1.5 Global Felodipine Sustained-Release Tablet Production Capacity Analysis
1.5.1 Global Felodipine Sustained-Release Tablet Total Production Capacity (2017-2028)
1.5.2 Global Felodipine Sustained-Release Tablet Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Felodipine Sustained-Release Tablet Market Drivers
1.6.2 Felodipine Sustained-Release Tablet Market Restraints
1.6.3 Felodipine Sustained-Release Tablet Trends Analysis
2 Manufacturers Profiles
2.1 Astrazeneca
2.1.1 Astrazeneca Details
2.1.2 Astrazeneca Major Business
2.1.3 Astrazeneca Felodipine Sustained-Release Tablet Product and Services
2.1.4 Astrazeneca Felodipine Sustained-Release Tablet Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 NanJing Easeheal Phaemaecutical
2.2.1 NanJing Easeheal Phaemaecutical Details
2.2.2 NanJing Easeheal Phaemaecutical Major Business
2.2.3 NanJing Easeheal Phaemaecutical Felodipine Sustained-Release Tablet Product and Services
2.2.4 NanJing Easeheal Phaemaecutical Felodipine Sustained-Release Tablet Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 SHANXI KANGBO BIOLOGICAL PRODUCT
2.3.1 SHANXI KANGBO BIOLOGICAL PRODUCT Details
2.3.2 SHANXI KANGBO BIOLOGICAL PRODUCT Major Business
2.3.3 SHANXI KANGBO BIOLOGICAL PRODUCT Felodipine Sustained-Release Tablet Product and Services
2.3.4 SHANXI KANGBO BIOLOGICAL PRODUCT Felodipine Sustained-Release Tablet Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Lifeon
2.4.1 Lifeon Details
2.4.2 Lifeon Major Business
2.4.3 Lifeon Felodipine Sustained-Release Tablet Product and Services
2.4.4 Lifeon Felodipine Sustained-Release Tablet Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Changzhou Siyao Pharmaceutical
2.5.1 Changzhou Siyao Pharmaceutical Details
2.5.2 Changzhou Siyao Pharmaceutical Major Business
2.5.3 Changzhou Siyao Pharmaceutical Felodipine Sustained-Release Tablet Product and Services
2.5.4 Changzhou Siyao Pharmaceutical Felodipine Sustained-Release Tablet Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 Mylan
2.6.1 Mylan Details
2.6.2 Mylan Major Business
2.6.3 Mylan Felodipine Sustained-Release Tablet Product and Services
2.6.4 Mylan Felodipine Sustained-Release Tablet Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 Sandoz
2.7.1 Sandoz Details
2.7.2 Sandoz Major Business
2.7.3 Sandoz Felodipine Sustained-Release Tablet Product and Services
2.7.4 Sandoz Felodipine Sustained-Release Tablet Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Felodipine Sustained-Release Tablet Breakdown Data by Manufacturer
3.1 Global Felodipine Sustained-Release Tablet Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Felodipine Sustained-Release Tablet Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Felodipine Sustained-Release Tablet
3.4 Market Concentration Rate
3.4.1 Top 3 Felodipine Sustained-Release Tablet Manufacturer Market Share in 2021
3.4.2 Top 6 Felodipine Sustained-Release Tablet Manufacturer Market Share in 2021
3.5 Global Felodipine Sustained-Release Tablet Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Felodipine Sustained-Release Tablet Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Felodipine Sustained-Release Tablet Market Size by Region
4.1.1 Global Felodipine Sustained-Release Tablet Sales in Volume by Region (2017-2028)
4.1.2 Global Felodipine Sustained-Release Tablet Revenue by Region (2017-2028)
4.2 North America Felodipine Sustained-Release Tablet Revenue (2017-2028)
4.3 Europe Felodipine Sustained-Release Tablet Revenue (2017-2028)
4.4 Asia-Pacific Felodipine Sustained-Release Tablet Revenue (2017-2028)
4.5 South America Felodipine Sustained-Release Tablet Revenue (2017-2028)
4.6 Middle East and Africa Felodipine Sustained-Release Tablet Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Felodipine Sustained-Release Tablet Sales in Volume by Type (2017-2028)
5.2 Global Felodipine Sustained-Release Tablet Revenue by Type (2017-2028)
5.3 Global Felodipine Sustained-Release Tablet Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Felodipine Sustained-Release Tablet Sales in Volume by Application (2017-2028)
6.2 Global Felodipine Sustained-Release Tablet Revenue by Application (2017-2028)
6.3 Global Felodipine Sustained-Release Tablet Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Felodipine Sustained-Release Tablet Sales by Type (2017-2028)
7.2 North America Felodipine Sustained-Release Tablet Sales by Application (2017-2028)
7.3 North America Felodipine Sustained-Release Tablet Market Size by Country
7.3.1 North America Felodipine Sustained-Release Tablet Sales in Volume by Country (2017-2028)
7.3.2 North America Felodipine Sustained-Release Tablet Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Felodipine Sustained-Release Tablet Sales by Type (2017-2028)
8.2 Europe Felodipine Sustained-Release Tablet Sales by Application (2017-2028)
8.3 Europe Felodipine Sustained-Release Tablet Market Size by Country
8.3.1 Europe Felodipine Sustained-Release Tablet Sales in Volume by Country (2017-2028)
8.3.2 Europe Felodipine Sustained-Release Tablet Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Felodipine Sustained-Release Tablet Sales by Type (2017-2028)
9.2 Asia-Pacific Felodipine Sustained-Release Tablet Sales by Application (2017-2028)
9.3 Asia-Pacific Felodipine Sustained-Release Tablet Market Size by Region
9.3.1 Asia-Pacific Felodipine Sustained-Release Tablet Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Felodipine Sustained-Release Tablet Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Felodipine Sustained-Release Tablet Sales by Type (2017-2028)
10.2 South America Felodipine Sustained-Release Tablet Sales by Application (2017-2028)
10.3 South America Felodipine Sustained-Release Tablet Market Size by Country
10.3.1 South America Felodipine Sustained-Release Tablet Sales in Volume by Country (2017-2028)
10.3.2 South America Felodipine Sustained-Release Tablet Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Felodipine Sustained-Release Tablet Sales by Type (2017-2028)
11.2 Middle East & Africa Felodipine Sustained-Release Tablet Sales by Application (2017-2028)
11.3 Middle East & Africa Felodipine Sustained-Release Tablet Market Size by Country
11.3.1 Middle East & Africa Felodipine Sustained-Release Tablet Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Felodipine Sustained-Release Tablet Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Felodipine Sustained-Release Tablet and Key Manufacturers
12.2 Manufacturing Costs Percentage of Felodipine Sustained-Release Tablet
12.3 Felodipine Sustained-Release Tablet Production Process
12.4 Felodipine Sustained-Release Tablet Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Felodipine Sustained-Release Tablet Typical Distributors
13.3 Felodipine Sustained-Release Tablet Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer

List of Tables
Table 1. Global Felodipine Sustained-Release Tablet Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Felodipine Sustained-Release Tablet Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. Astrazeneca Basic Information, Manufacturing Base and Competitors
Table 4. Astrazeneca Major Business
Table 5. Astrazeneca Felodipine Sustained-Release Tablet Product and Services
Table 6. Astrazeneca Felodipine Sustained-Release Tablet Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. NanJing Easeheal Phaemaecutical Basic Information, Manufacturing Base and Competitors
Table 8. NanJing Easeheal Phaemaecutical Major Business
Table 9. NanJing Easeheal Phaemaecutical Felodipine Sustained-Release Tablet Product and Services
Table 10. NanJing Easeheal Phaemaecutical Felodipine Sustained-Release Tablet Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. SHANXI KANGBO BIOLOGICAL PRODUCT Basic Information, Manufacturing Base and Competitors
Table 12. SHANXI KANGBO BIOLOGICAL PRODUCT Major Business
Table 13. SHANXI KANGBO BIOLOGICAL PRODUCT Felodipine Sustained-Release Tablet Product and Services
Table 14. SHANXI KANGBO BIOLOGICAL PRODUCT Felodipine Sustained-Release Tablet Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. Lifeon Basic Information, Manufacturing Base and Competitors
Table 16. Lifeon Major Business
Table 17. Lifeon Felodipine Sustained-Release Tablet Product and Services
Table 18. Lifeon Felodipine Sustained-Release Tablet Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. Changzhou Siyao Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 20. Changzhou Siyao Pharmaceutical Major Business
Table 21. Changzhou Siyao Pharmaceutical Felodipine Sustained-Release Tablet Product and Services
Table 22. Changzhou Siyao Pharmaceutical Felodipine Sustained-Release Tablet Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 23. Mylan Basic Information, Manufacturing Base and Competitors
Table 24. Mylan Major Business
Table 25. Mylan Felodipine Sustained-Release Tablet Product and Services
Table 26. Mylan Felodipine Sustained-Release Tablet Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 27. Sandoz Basic Information, Manufacturing Base and Competitors
Table 28. Sandoz Major Business
Table 29. Sandoz Felodipine Sustained-Release Tablet Product and Services
Table 30. Sandoz Felodipine Sustained-Release Tablet Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 31. Global Felodipine Sustained-Release Tablet Sales by Manufacturer (2019, 2020, 2021, and 2022) & (K Units)
Table 32. Global Felodipine Sustained-Release Tablet Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 33. Market Position of Manufacturers in Felodipine Sustained-Release Tablet, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 34. Global Felodipine Sustained-Release Tablet Production Capacity by Company, (K Units): 2020 VS 2021
Table 35. Head Office and Felodipine Sustained-Release Tablet Production Site of Key Manufacturer
Table 36. Felodipine Sustained-Release Tablet New Entrant and Capacity Expansion Plans
Table 37. Felodipine Sustained-Release Tablet Mergers & Acquisitions in the Past Five Years
Table 38. Global Felodipine Sustained-Release Tablet Sales by Region (2017-2022) & (K Units)
Table 39. Global Felodipine Sustained-Release Tablet Sales by Region (2023-2028) & (K Units)
Table 40. Global Felodipine Sustained-Release Tablet Revenue by Region (2017-2022) & (USD Million)
Table 41. Global Felodipine Sustained-Release Tablet Revenue by Region (2023-2028) & (USD Million)
Table 42. Global Felodipine Sustained-Release Tablet Sales by Type (2017-2022) & (K Units)
Table 43. Global Felodipine Sustained-Release Tablet Sales by Type (2023-2028) & (K Units)
Table 44. Global Felodipine Sustained-Release Tablet Revenue by Type (2017-2022) & (USD Million)
Table 45. Global Felodipine Sustained-Release Tablet Revenue by Type (2023-2028) & (USD Million)
Table 46. Global Felodipine Sustained-Release Tablet Price by Type (2017-2022) & (US$/Unit)
Table 47. Global Felodipine Sustained-Release Tablet Price by Type (2023-2028) & (US$/Unit)
Table 48. Global Felodipine Sustained-Release Tablet Sales by Application (2017-2022) & (K Units)
Table 49. Global Felodipine Sustained-Release Tablet Sales by Application (2023-2028) & (K Units)
Table 50. Global Felodipine Sustained-Release Tablet Revenue by Application (2017-2022) & (USD Million)
Table 51. Global Felodipine Sustained-Release Tablet Revenue by Application (2023-2028) & (USD Million)
Table 52. Global Felodipine Sustained-Release Tablet Price by Application (2017-2022) & (US$/Unit)
Table 53. Global Felodipine Sustained-Release Tablet Price by Application (2023-2028) & (US$/Unit)
Table 54. North America Felodipine Sustained-Release Tablet Sales by Country (2017-2022) & (K Units)
Table 55. North America Felodipine Sustained-Release Tablet Sales by Country (2023-2028) & (K Units)
Table 56. North America Felodipine Sustained-Release Tablet Revenue by Country (2017-2022) & (USD Million)
Table 57. North America Felodipine Sustained-Release Tablet Revenue by Country (2023-2028) & (USD Million)
Table 58. North America Felodipine Sustained-Release Tablet Sales by Type (2017-2022) & (K Units)
Table 59. North America Felodipine Sustained-Release Tablet Sales by Type (2023-2028) & (K Units)
Table 60. North America Felodipine Sustained-Release Tablet Sales by Application (2017-2022) & (K Units)
Table 61. North America Felodipine Sustained-Release Tablet Sales by Application (2023-2028) & (K Units)
Table 62. Europe Felodipine Sustained-Release Tablet Sales by Country (2017-2022) & (K Units)
Table 63. Europe Felodipine Sustained-Release Tablet Sales by Country (2023-2028) & (K Units)
Table 64. Europe Felodipine Sustained-Release Tablet Revenue by Country (2017-2022) & (USD Million)
Table 65. Europe Felodipine Sustained-Release Tablet Revenue by Country (2023-2028) & (USD Million)
Table 66. Europe Felodipine Sustained-Release Tablet Sales by Type (2017-2022) & (K Units)
Table 67. Europe Felodipine Sustained-Release Tablet Sales by Type (2023-2028) & (K Units)
Table 68. Europe Felodipine Sustained-Release Tablet Sales by Application (2017-2022) & (K Units)
Table 69. Europe Felodipine Sustained-Release Tablet Sales by Application (2023-2028) & (K Units)
Table 70. Asia-Pacific Felodipine Sustained-Release Tablet Sales by Region (2017-2022) & (K Units)
Table 71. Asia-Pacific Felodipine Sustained-Release Tablet Sales by Region (2023-2028) & (K Units)
Table 72. Asia-Pacific Felodipine Sustained-Release Tablet Revenue by Region (2017-2022) & (USD Million)
Table 73. Asia-Pacific Felodipine Sustained-Release Tablet Revenue by Region (2023-2028) & (USD Million)
Table 74. Asia-Pacific Felodipine Sustained-Release Tablet Sales by Type (2017-2022) & (K Units)
Table 75. Asia-Pacific Felodipine Sustained-Release Tablet Sales by Type (2023-2028) & (K Units)
Table 76. Asia-Pacific Felodipine Sustained-Release Tablet Sales by Application (2017-2022) & (K Units)
Table 77. Asia-Pacific Felodipine Sustained-Release Tablet Sales by Application (2023-2028) & (K Units)
Table 78. South America Felodipine Sustained-Release Tablet Sales by Country (2017-2022) & (K Units)
Table 79. South America Felodipine Sustained-Release Tablet Sales by Country (2023-2028) & (K Units)
Table 80. South America Felodipine Sustained-Release Tablet Revenue by Country (2017-2022) & (USD Million)
Table 81. South America Felodipine Sustained-Release Tablet Revenue by Country (2023-2028) & (USD Million)
Table 82. South America Felodipine Sustained-Release Tablet Sales by Type (2017-2022) & (K Units)
Table 83. South America Felodipine Sustained-Release Tablet Sales by Type (2023-2028) & (K Units)
Table 84. South America Felodipine Sustained-Release Tablet Sales by Application (2017-2022) & (K Units)
Table 85. South America Felodipine Sustained-Release Tablet Sales by Application (2023-2028) & (K Units)
Table 86. Middle East & Africa Felodipine Sustained-Release Tablet Sales by Region (2017-2022) & (K Units)
Table 87. Middle East & Africa Felodipine Sustained-Release Tablet Sales by Region (2023-2028) & (K Units)
Table 88. Middle East & Africa Felodipine Sustained-Release Tablet Revenue by Region (2017-2022) & (USD Million)
Table 89. Middle East & Africa Felodipine Sustained-Release Tablet Revenue by Region (2023-2028) & (USD Million)
Table 90. Middle East & Africa Felodipine Sustained-Release Tablet Sales by Type (2017-2022) & (K Units)
Table 91. Middle East & Africa Felodipine Sustained-Release Tablet Sales by Type (2023-2028) & (K Units)
Table 92. Middle East & Africa Felodipine Sustained-Release Tablet Sales by Application (2017-2022) & (K Units)
Table 93. Middle East & Africa Felodipine Sustained-Release Tablet Sales by Application (2023-2028) & (K Units)
Table 94. Felodipine Sustained-Release Tablet Raw Material
Table 95. Key Manufacturers of Felodipine Sustained-Release Tablet Raw Materials
Table 96. Direct Channel Pros & Cons
Table 97. Indirect Channel Pros & Cons
Table 98. Felodipine Sustained-Release Tablet Typical Distributors
Table 99. Felodipine Sustained-Release Tablet Typical Customers
List of Figures
Figure 1. Felodipine Sustained-Release Tablet Picture
Figure 2. Global Felodipine Sustained-Release Tablet Revenue Market Share by Type in 2021
Figure 3. 2.5mg Per Tablet
Figure 4. 5mg Per Tablet
Figure 5. Others
Figure 6. Global Felodipine Sustained-Release Tablet Revenue Market Share by Application in 2021
Figure 7. Treat High Blood Pressure
Figure 8. Relieve Angina
Figure 9. Others
Figure 10. Global Felodipine Sustained-Release Tablet Revenue, (USD Million) & (K Units): 2017 & 2021 & 2028
Figure 11. Global Felodipine Sustained-Release Tablet Revenue and Forecast (2017-2028) & (USD Million)
Figure 12. Global Felodipine Sustained-Release Tablet Sales (2017-2028) & (K Units)
Figure 13. Global Felodipine Sustained-Release Tablet Price (2017-2028) & (US$/Unit)
Figure 14. Global Felodipine Sustained-Release Tablet Production Capacity (2017-2028) & (K Units)
Figure 15. Global Felodipine Sustained-Release Tablet Production Capacity by Geographic Region: 2022 VS 2028
Figure 16. Felodipine Sustained-Release Tablet Market Drivers
Figure 17. Felodipine Sustained-Release Tablet Market Restraints
Figure 18. Felodipine Sustained-Release Tablet Market Trends
Figure 19. Global Felodipine Sustained-Release Tablet Sales Market Share by Manufacturer in 2021
Figure 20. Global Felodipine Sustained-Release Tablet Revenue Market Share by Manufacturer in 2021
Figure 21. Felodipine Sustained-Release Tablet Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 22. Top 3 Felodipine Sustained-Release Tablet Manufacturer (Revenue) Market Share in 2021
Figure 23. Top 6 Felodipine Sustained-Release Tablet Manufacturer (Revenue) Market Share in 2021
Figure 24. Global Felodipine Sustained-Release Tablet Sales Market Share by Region (2017-2028)
Figure 25. Global Felodipine Sustained-Release Tablet Revenue Market Share by Region (2017-2028)
Figure 26. North America Felodipine Sustained-Release Tablet Revenue (2017-2028) & (USD Million)
Figure 27. Europe Felodipine Sustained-Release Tablet Revenue (2017-2028) & (USD Million)
Figure 28. Asia-Pacific Felodipine Sustained-Release Tablet Revenue (2017-2028) & (USD Million)
Figure 29. South America Felodipine Sustained-Release Tablet Revenue (2017-2028) & (USD Million)
Figure 30. Middle East & Africa Felodipine Sustained-Release Tablet Revenue (2017-2028) & (USD Million)
Figure 31. Global Felodipine Sustained-Release Tablet Sales Market Share by Type (2017-2028)
Figure 32. Global Felodipine Sustained-Release Tablet Revenue Market Share by Type (2017-2028)
Figure 33. Global Felodipine Sustained-Release Tablet Price by Type (2017-2028) & (US$/Unit)
Figure 34. Global Felodipine Sustained-Release Tablet Sales Market Share by Application (2017-2028)
Figure 35. Global Felodipine Sustained-Release Tablet Revenue Market Share by Application (2017-2028)
Figure 36. Global Felodipine Sustained-Release Tablet Price by Application (2017-2028) & (US$/Unit)
Figure 37. North America Felodipine Sustained-Release Tablet Sales Market Share by Type (2017-2028)
Figure 38. North America Felodipine Sustained-Release Tablet Sales Market Share by Application (2017-2028)
Figure 39. North America Felodipine Sustained-Release Tablet Sales Market Share by Country (2017-2028)
Figure 40. North America Felodipine Sustained-Release Tablet Revenue Market Share by Country (2017-2028)
Figure 41. United States Felodipine Sustained-Release Tablet Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 42. Canada Felodipine Sustained-Release Tablet Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 43. Mexico Felodipine Sustained-Release Tablet Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 44. Europe Felodipine Sustained-Release Tablet Sales Market Share by Type (2017-2028)
Figure 45. Europe Felodipine Sustained-Release Tablet Sales Market Share by Application (2017-2028)
Figure 46. Europe Felodipine Sustained-Release Tablet Sales Market Share by Country (2017-2028)
Figure 47. Europe Felodipine Sustained-Release Tablet Revenue Market Share by Country (2017-2028)
Figure 48. Germany Felodipine Sustained-Release Tablet Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 49. France Felodipine Sustained-Release Tablet Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. United Kingdom Felodipine Sustained-Release Tablet Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. Russia Felodipine Sustained-Release Tablet Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. Italy Felodipine Sustained-Release Tablet Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 53. Asia-Pacific Felodipine Sustained-Release Tablet Sales Market Share by Region (2017-2028)
Figure 54. Asia-Pacific Felodipine Sustained-Release Tablet Sales Market Share by Application (2017-2028)
Figure 55. Asia-Pacific Felodipine Sustained-Release Tablet Sales Market Share by Region (2017-2028)
Figure 56. Asia-Pacific Felodipine Sustained-Release Tablet Revenue Market Share by Region (2017-2028)
Figure 57. China Felodipine Sustained-Release Tablet Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. Japan Felodipine Sustained-Release Tablet Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. Korea Felodipine Sustained-Release Tablet Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. India Felodipine Sustained-Release Tablet Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. Southeast Asia Felodipine Sustained-Release Tablet Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. Australia Felodipine Sustained-Release Tablet Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 63. South America Felodipine Sustained-Release Tablet Sales Market Share by Type (2017-2028)
Figure 64. South America Felodipine Sustained-Release Tablet Sales Market Share by Application (2017-2028)
Figure 65. South America Felodipine Sustained-Release Tablet Sales Market Share by Country (2017-2028)
Figure 66. South America Felodipine Sustained-Release Tablet Revenue Market Share by Country (2017-2028)
Figure 67. Brazil Felodipine Sustained-Release Tablet Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 68. Argentina Felodipine Sustained-Release Tablet Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 69. Middle East & Africa Felodipine Sustained-Release Tablet Sales Market Share by Type (2017-2028)
Figure 70. Middle East & Africa Felodipine Sustained-Release Tablet Sales Market Share by Application (2017-2028)
Figure 71. Middle East & Africa Felodipine Sustained-Release Tablet Sales Market Share by Region (2017-2028)
Figure 72. Middle East & Africa Felodipine Sustained-Release Tablet Revenue Market Share by Region (2017-2028)
Figure 73. Turkey Felodipine Sustained-Release Tablet Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 74. Egypt Felodipine Sustained-Release Tablet Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. Saudi Arabia Felodipine Sustained-Release Tablet Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 76. South Africa Felodipine Sustained-Release Tablet Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 77. Manufacturing Cost Structure Analysis of Felodipine Sustained-Release Tablet in 2021
Figure 78. Manufacturing Process Analysis of Felodipine Sustained-Release Tablet
Figure 79. Felodipine Sustained-Release Tablet Industrial Chain
Figure 80. Sales Channel: Direct Channel vs Indirect Channel
Figure 81. Methodology
Figure 82. Research Process and Data Source

❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 世界のフェロジピン徐放性錠剤市場2022年：1錠あたり2.5mg、1錠あたり5mg、その他(Global Felodipine Sustained-Release Tablet Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028)]についてメールでお問い合わせはこちらでお願いします。

GlobalResearch.jp

世界のフェロジピン徐放性錠剤市場2022年：1錠あたり2.5mg、1錠あたり5mg、その他

グローバル市場調査/マーケットリサーチ会社：レポート販売と委託調査サービス提供 www.GlobalResearch.jp